Using generative AI combined with immersive technology to treat anxiety disorders

利用生成式人工智能结合沉浸式技术治疗焦虑症

• 批准号: 10109165
• 金额: $ 12.72万
• 依托单位: XR THERAPEUTICS LIMITED
• 依托单位国家: 英国
• 项目类别: Launchpad
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10109165
• 关键词: Using; generative; AI; combined; immersive

XR Therapeutics is a start-up company, spun out of Newcastle University which has been based on over 9 years of clinical and academic research. Our service combines traditional CBT (Cognitive Behavioural Therapy) with gradual exposure therapy to treat phobias and situation specific anxiety. Our solution is delivered using VR (Virtual Reality) technology within a fully immersive environment. The unique treatment can be adapted by the therapist in real time via a tablet, as we work alongside clinicians and end users to tailor scenes based on the needs of the recipient. Administering traditional CBT to an individual can take anywhere between 12 to 20 sessions before the patient observes noticeable impact. Our treatment can shorten this to 2 sessions over a 2-week period, and when treating anxiety disorders, this can be achieved in just 1 session. XR Therapeutics is commercially delivering VR supported therapies. This means that we already have established commercial relationships with private health insurers, therapists and major NHS trusts, giving us a clear route to market for an expanded solution.This is an 12-month project that will use the funding received to implement AI generative tools to make our intervention quicker and responsive to the needs of patients.We aim to utilise Open Source AI platforms that have an inherent spatial understanding of 3d space.Work to Date: Our platform initially focused on supporting autistic adults and children with phobias. Two tranches of previous Innovate UK support enabled us to establish the spinout and expand our innovation to the wider market of neurotypical adults. We are now successfully delivering VR therapies through commercial relationships with NHS Trusts, private treatments, and private insurers.Need: Official mental health waiting lists have doubled as a result of Covid to 1.6M people. However, NHS England has estimated that 8M people who would benefit from mental health services are unable to access them due to lack of capacity (NHS England, 2021). This means that people are waiting upwards of 9 months to begin treatment. We use our intervention to support healthcare providers by supplying a more efficient solution that patients only have to wait up to 2 weeks for and can be completed within 2 weeks through 2 sessions.

XR Therapeutics是一家初创公司，是从纽卡斯尔大学（Newcastle University）开发的，它基于9年以上的临床和学术研究。我们的服务结合了传统的CBT（认知行为疗法）和逐渐暴露疗法，以治疗恐惧症和特定情况焦虑。我们的解决方案是在完全沉浸式环境中使用VR（虚拟现实）技术提供的。当我们与临床医生和最终用户一起工作以根据收件人的需求与临床医生和最终用户一起工作，可以通过平板电脑实时对治疗师进行独特的治疗。在患者观察出明显的影响之前，向个人管理传统的CBT可以参加12至20个课程。我们的治疗方法可以在2周的时间内将其缩短为2次，并且在治疗焦虑症时，这可以在仅1次会议中实现。 XR Therapeutics正在商业上提供VR支持的疗法。这意味着我们已经与私人健康保险公司，治疗师和主要NHS信托建立了商业关系，为我们提供了通往市场的明确途径，以扩大解决方案。这是一个12个月的项目，该项目将使用收到的资金来实施AI生成工具，以使我们的干预更快地响应我们的干预措施，以使我们对患者的需求更快，旨在利用固有的空间来理解固有的Spectial Aim ai ai ai ai ai ai ai nii spatial ai nii of in ai ai ai n of of Spatial Antim。自闭症成年人和恐惧症儿童。英国以前的两次创新支持使我们能够建立旋转并将创新扩展到更广泛的神经型成人市场。现在，我们通过与NHS信托，私人治疗和私人保险公司的商业关系成功地提供了VR疗法。需要：官方的心理健康等待名单由于COVID的结果增加了一倍，达到160万人。但是，NHS英格兰估计，由于缺乏能力，将从精神卫生服务中受益的800万人无法获得他们（NHS England，2021年）。这意味着人们正在等待9个月以上开始治疗。我们通过提供更有效的解决方案来使用干预措施来支持医疗保健提供者，该解决方案只需要等待2周，并且可以在2周内完成2个课程完成。